KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $60.2 million.

  • Dynavax Technologies' Free Cash Flow rose 79.86% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.5 million, marking a year-over-year increase of 255.26%. This contributed to the annual value of $60.2 million for FY2024, which is 37.63% down from last year.
  • As of FY2024, Dynavax Technologies' Free Cash Flow stood at $60.2 million, which was down 37.63% from $96.5 million recorded in FY2023.
  • Dynavax Technologies' Free Cash Flow's 5-year high stood at $326.1 million during FY2021, with a 5-year trough of -$96.3 million in FY2020.
  • Moreover, its 3-year median value for Free Cash Flow was $60.2 million (2024), whereas its average is $70.7 million.
  • As far as peak fluctuations go, Dynavax Technologies' Free Cash Flow surged by 438.50% in 2021, and later crashed by 82.95% in 2022.
  • Dynavax Technologies' Free Cash Flow (Yearly) stood at -$96.3 million in 2020, then spiked by 438.50% to $326.1 million in 2021, then plummeted by 82.95% to $55.6 million in 2022, then soared by 73.56% to $96.5 million in 2023, then tumbled by 37.63% to $60.2 million in 2024.